Newsletter May 2023 No.215
Top News
Japan is striving to revive itself as a nation of science and technology. At the 34th JPMA Policy Seminar held on March 13, 2023, experts from various fields who are leading various innovations took the stage. The seminar offered many proposals on how to revitalize the drug discovery ecosystem, including promotion of medical digital transformation (DX), utilization of rapidly developing artificial intelligence (AI), formation of bioclusters, fostering startups, and utilization of data such as personal health records (PHRs). Many proposals were made to revitalize the drug discovery ecosystem. The following is a transcript of the seminar.
Topics
- Holding of "2023 Life Science Intellectual Property Forum" -Current Status, Prospects and Challenges of Digital Therapeutics (DTx)
- The 9th Japan-Thailand Joint Symposium" will be held
- The 6th Japan-India Symposium on Regulation of Medical Products
- Meeting of Compliance Managers and Practitioners for Fiscal Year 2022
- JPMA Media Forum" held -Trends in science, technology and innovation from a bird's eye view of the life science field and their implications for the drug discovery field
Policy Research Institute
From JPMA
Industry's Own Reforms to Improve its Ability to Create Innovations